Flow Traders U.S.’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $232K | Sell |
2,801
-9,734
| -78% | -$806K | 0.01% | 812 |
|
2025
Q1 | $1.02M | Buy |
+12,535
| New | +$1.02M | 0.04% | 394 |
|
2024
Q2 | – | Sell |
-17,792
| Closed | -$1.69M | – | 1110 |
|
2024
Q1 | $1.69M | Buy |
17,792
+11,834
| +199% | +$1.12M | 0.09% | 208 |
|
2023
Q4 | $532K | Buy |
+5,958
| New | +$532K | 0.02% | 484 |
|
2023
Q2 | – | Sell |
-36,927
| Closed | -$2.81M | – | 1125 |
|
2023
Q1 | $2.81M | Buy |
+36,927
| New | +$2.81M | 0.11% | 134 |
|
2021
Q3 | – | Sell |
-4,907
| Closed | -$664K | – | 1303 |
|
2021
Q2 | $664K | Buy |
+4,907
| New | +$664K | 0.03% | 512 |
|
2020
Q4 | – | Sell |
-17,769
| Closed | -$1.98M | – | 797 |
|
2020
Q3 | $1.98M | Sell |
17,769
-3,800
| -18% | -$423K | 0.15% | 143 |
|
2020
Q2 | $2.42M | Buy |
+21,569
| New | +$2.42M | 0.19% | 103 |
|
2017
Q2 | – | Sell |
-7,260
| Closed | -$503K | – | 358 |
|
2017
Q1 | $503K | Buy |
7,260
+269
| +4% | +$18.6K | 0.04% | 206 |
|
2016
Q4 | $414K | Buy |
+6,991
| New | +$414K | 0.03% | 226 |
|
2016
Q3 | – | Sell |
-4,132
| Closed | -$223K | – | 476 |
|
2016
Q2 | $223K | Sell |
4,132
-100,452
| -96% | -$5.42M | 0.02% | 173 |
|
2016
Q1 | $5.4M | Buy |
+104,584
| New | +$5.4M | 0.55% | 41 |
|
2014
Q3 | – | Sell |
-6
| Closed | – | – | 225 |
|
2014
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 240 |
|